These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 5030811)

  • 21. Intensive combined chemotherapy and radiotherapy in patients with nonresectable bronchogenic carcinoma.
    Hansen HH; Muggia FM; Andrews R; Selawry OS
    Cancer; 1972 Aug; 30(2):315-24. PubMed ID: 4559404
    [No Abstract]   [Full Text] [Related]  

  • 22. Toxicity studies of fluorouracil used with adrenalectomy in breast cancer.
    Piro AJ; Wilson RE; Hall TC; Aliapoulios MA; Nevinny HB; Moore FD
    Arch Surg; 1972 Jul; 105(1):95-9. PubMed ID: 5031606
    [No Abstract]   [Full Text] [Related]  

  • 23. 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of malignant tumors other than melanoma.
    Kingra GS; Comis R; Olson KB; Horton J
    Cancer Chemother Rep; 1971 Jun; 55(3):281-3. PubMed ID: 5115849
    [No Abstract]   [Full Text] [Related]  

  • 24. A clinical study of fluorouracil.
    Nadler SH; Moore GE
    Surg Gynecol Obstet; 1968 Dec; 127(6):1210-4. PubMed ID: 4882472
    [No Abstract]   [Full Text] [Related]  

  • 25. A phase 2 study of intermittent high dose isophosphamide therapy of advanced colorectal cancer.
    Kovach JS; Schutt AJ; Hahn RG; Reitemeier RJ; Moertel CG
    Oncology; 1974; 29(1):34-9. PubMed ID: 4837137
    [No Abstract]   [Full Text] [Related]  

  • 26. Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
    Windschitl H; Scott M; Schutt A; McCormack G; Everson L; Cullinan S; Gerstner J; Krook J; Laurie J; Shreck R
    Cancer Treat Rep; 1983 Nov; 67(11):1001-8. PubMed ID: 6640551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II study of 5-azacytidine (NSC-102816) in the treatment of advanced gastrointestinal cancer.
    Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Chemother Rep; 1972 Oct; 56(5):649-52. PubMed ID: 4119908
    [No Abstract]   [Full Text] [Related]  

  • 28. Nursing management--cancer chemotherapy.
    Lane CG
    J Nurs Care; 1980 Oct; 13(10):7-11. PubMed ID: 6903601
    [No Abstract]   [Full Text] [Related]  

  • 29. Bleomycin (NSC-125066): phase I clinical study.
    Sonntag RW
    Cancer Chemother Rep; 1972 Apr; 56(2):197-205. PubMed ID: 4114485
    [No Abstract]   [Full Text] [Related]  

  • 30. Phase I clinical and pharmacokinetic study of taxol.
    Wiernik PH; Schwartz EL; Strauman JJ; Dutcher JP; Lipton RB; Paietta E
    Cancer Res; 1987 May; 47(9):2486-93. PubMed ID: 2882837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The acute toxicities of chemotherapy.
    Spiegel RJ
    Cancer Treat Rev; 1981 Sep; 8(3):197-207. PubMed ID: 7307016
    [No Abstract]   [Full Text] [Related]  

  • 32. A phase II study of triazinate (NSC 139105) in advanced colorectal carcinoma.
    McCreary RH; Moertel CG; Schutt AJ; O'Connell MJ; Hahn RG; Reitemeier RJ; Rubin J; Frytak S
    Cancer; 1977 Jul; 40(1):9-13. PubMed ID: 141977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of treatment of metastatic gastrointestinal cancer with 5-fluorouracil (5-FU) to a combination of 5-FU with cytosine arabinoside.
    Gailani S; Holland JF; Falkson G; Leone L; Burningham R; Larsen V
    Cancer; 1972 May; 29(5):1308-13. PubMed ID: 4623252
    [No Abstract]   [Full Text] [Related]  

  • 34. A controlled evaluation of 5-fluorouracil utilizing a single injection technique.
    Ahmann DL; Moertel CG; Bisel HF; Hahn RG; Schutt AJ; Dines DE
    Oncology; 1974; 29(2):166-71. PubMed ID: 4836677
    [No Abstract]   [Full Text] [Related]  

  • 35. Phase I study of chromomycin A (NSC-58514).
    Kovach JS; Moertel CG; Ahmann DL; Hahn RG; Schutt AJ; Donadio JV
    Cancer Chemother Rep; 1973; 57(3):341-7. PubMed ID: 4751258
    [No Abstract]   [Full Text] [Related]  

  • 36. Safety and tolerance of Navelbine in phase I-II clinical studies.
    Besenval M; Delgado M; Demarez JP; Krikorian A
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):37-40. PubMed ID: 2540533
    [No Abstract]   [Full Text] [Related]  

  • 37. [Dose escalation of domestic nedaplatin used in concurrent chemoradiotherapy for cervical cancer].
    Zhu WG; Yu CH; Li T
    Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):525-6. PubMed ID: 22093631
    [No Abstract]   [Full Text] [Related]  

  • 38. [Gastrointestinal complication of cancer chemotherapy].
    Hamaguchi T
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():281-6. PubMed ID: 18074549
    [No Abstract]   [Full Text] [Related]  

  • 39. Investigation into the usefulness and adverse events of CDDP, 5-fU and dl-leucovorin (PFL-therapy) for advanced colorectal cancer.
    Okabe S; Ishikawa T; Tanami H; Kuwabara H; Fukahara T; Udagawa M; Ootsukasa S; Arai T; Maruyama S; Murase N; Yamashita H; Iwai T
    J Med Dent Sci; 2002 Jun; 49(2):77-84. PubMed ID: 12627817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Side effects associated with pediatric chemotherapy: management and patient education issues.
    Lilley LL
    Pediatr Nurs; 1990; 16(3):252-5, 272. PubMed ID: 2359653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.